Sofinnova closes Fund XIII on €300m

The lifescience investor topped its €250 million target tapping investors primarily in Europe and some in North America.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this